Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Tuesday, April 1st, 2025

Morningstar’s 10 Cheapest Wide-Moat US Stocks for 2025: Estee Lauder, Pfizer, Nike Lead the Pack

Morningstar Equity Research has unveiled its 10 “cheap, wide-moat” US stocks for 2025, spotlighting companies with strong competitive advantages that enable them to fend off rivals and deliver long-term value to investors.

What Are Wide-Moat Stocks?

Wide-moat stocks represent companies with enduring competitive edges built through strategies like:

  • High switching costs for customers.
  • Iconic brand identities that inspire loyalty.
  • Economies of scale that keep costs low and profitability high.

These companies also boast sound balance sheets, making them desirable picks amid today’s economic uncertainties, says Susan Dziubinski, an investment specialist at Morningstar. She notes that investing in wide-moat stocks trading at a discount to their fair value has historically been a successful strategy.

The Top 10 Undervalued Wide-Moat Stocks

As of Dec 27, 2024, the 10 most undervalued wide-moat stocks, according to the Morningstar Wide Moat Focus Index, are:

  1. Estee Lauder (EL)
    • Trading 54% below fair value, making it the most undervalued on the list.
    • Its shares have fallen 47% in 2024, closing at US$73.98 on Jan 2.
  2. Huntington Ingalls Industries (HII)
  3. Pfizer (PFE)
  4. International Flavors & Fragrances (IFF)
    • The only stock with a price increase in 2024, up 2.05% year-on-year.
  5. Nike (NKE)
  6. Campbell Company (CPB)
    • Shares declined the least, falling just 6% to US$42.03.
  7. Brown-Forman (BF.B)
  8. Zimmer Biomet (ZBH)
  9. NXP Semiconductors (NXPI)
  10. MarketAxess Holdings (MKTX)
    • Trading 25% below fair value, the least undervalued stock on the list.

Why These Stocks Matter

“These wide-moat stocks represent high-quality opportunities for long-term investors, particularly those looking for discounted investments,” says Dziubinski. Companies like Estee Lauder and Pfizer bring a combination of resilience and growth potential, making them compelling picks for 2025.

Performance in 2024

The list reflects diverse performance:

  • Biggest decline: Estee Lauder’s shares tumbled 47% in 2024.
  • Steady performers: Campbell’s Co weathered the storm, dropping just 6%.
  • Notable growth: International Flavors & Fragrances bucked the trend, gaining 2.05%.

An Investment Opportunity

While markets face uncertainties, Morningstar believes these stocks are positioned to thrive in the long run. With sound fundamentals and significant discounts to fair value, they offer investors a chance to buy into companies with decades of competitive dominance at compelling prices.

For long-term value hunters, Morningstar’s wide-moat picks could be the cornerstone of a resilient portfolio in 2025.

Thank you

Suntec REIT Downgraded to ‘Sell’ Amid Concerns Over Operational Performance and Market Uncertainties

Date of Report and Broker Name Date: 20 September 2024 Broker: OCBC Investment Research Company OverviewSuntec REIT, listed on 9 December 2004, holds a diversified portfolio of high-quality properties in Singapore, Australia, and the...

“ST Engineering 2025 Outlook: Strong Growth Drivers, Record-High Order Book & ESG Leadership”

Executive Summary This comprehensive report provides a detailed look into ST Engineering, a leading conglomerate in Singapore that is transforming its business through strategic focus on its high‐growth segments: Commercial Aerospace, Urban Solutions &...

“Capitaland Investment 2025: Growth Strategies, Financial Highlights, and ESG Insights”

Overview This comprehensive research report provides an in‐depth analysis of Capitaland Investment (CLI SP) with a primary focus on its growth prospects, evolving business segments, financial performance, and ESG profile. The report further expands...